Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 271
Filter
1.
Biomed Res Int ; 2021: 9928276, 2021.
Article in English | MEDLINE | ID: mdl-34963882

ABSTRACT

INTRODUCTION: Coronavirus disease 2019 (COVID-19) is a global public health crisis. However, whether it can cause respiratory dysfunction or physical and psychological disorders in patients remains unknown. Thus, this study was conducted to investigate the respiratory function, activities of daily living, quality of life, and mental status of patients with COVID-19. Participants and outcomes. Data was collected from the follow-up of eligible patients who attended the fever clinic of three hospitals in Jiangxi Province, from March to May 2020. The outcomes included respiratory muscle function, degree of dyspnea, aerobic capacity, activities of daily living, quality of life, and mental status. RESULTS: A total of 139 patients (72 men and 67 women) were included in this study. The proportions of mild, moderate, severe, and critical cases of COVID-19 were 7.1% (10 cases), 68.3% (95 cases), 20.1% (28 cases), and 4.2% (6 cases), respectively. The rates of abnormal maximal inspiratory pressure were 10.0%, 25.2%, 25.0%, and 16.7%, respectively. There were 50%, 65.3%, 50%, and 66.7% of the patients with abnormal dyspnea in the four clinical classifications, respectively. Patients generally show a decline in quality of life, anxiety, and depression symptoms. CONCLUSIONS: Respiratory dysfunction, decreased quality of life, and psychological disorders were present in each clinical classification of COVID-19. Therefore, it is necessary to carry out respiratory rehabilitation and psychological intervention for COVID-19 patients.


Subject(s)
Activities of Daily Living , COVID-19 , Quality of Life , Respiratory Mechanics , SARS-CoV-2 , Adult , Aged , Anxiety/physiopathology , Anxiety/psychology , Anxiety/rehabilitation , COVID-19/physiopathology , COVID-19/psychology , COVID-19/rehabilitation , Depression/physiopathology , Depression/psychology , Depression/rehabilitation , Female , Follow-Up Studies , Humans , Male , Middle Aged , Prospective Studies
2.
Am J Phys Med Rehabil ; 100(12): 1140-1147, 2021 12 01.
Article in English | MEDLINE | ID: mdl-34793374

ABSTRACT

ABSTRACT: The long-term sequelae after SARS-CoV-2 infections in children is unknown. Guidance is needed on helpful models of care for an emerging subset of pediatric patients with postacute/long COVID who continue to experience persistent symptoms after initial COVID-19 diagnosis. Here, we describe a pediatric multidisciplinary post-COVID-19 rehabilitation clinic model as well as a case series of the initial cohort of patients who presented to this clinic. A consecutive sample of nine patients (pediatric patients <21 yrs of age) who presented to our clinic are included. The most common presenting symptoms were fatigue (8 of 9 patients), headaches (6 of 9), difficulty with schoolwork (6 of 8), "brain fog" (4 of 9), and dizziness/lightheadedness (4 of 9). Most patients had decreased scores on self-reported quality-of-life measures compared with healthy controls. In the patients who participated in neuropsychological testing, a subset demonstrated difficulties with sustained auditory attention and divided attention; however, most of these patients had preexisting attention and/or mood concerns. There were also some who self-reported elevated depression and anxiety symptoms. Pediatric patients with postacute/long COVID may present with a variety of physical, cognitive, and mood symptoms. We present a model of care to address these symptoms through a multidisciplinary rehabilitation approach.


Subject(s)
COVID-19/complications , COVID-19/rehabilitation , Patient Care Team , Pediatrics/methods , Subacute Care/methods , Adolescent , Anxiety/rehabilitation , Anxiety/virology , COVID-19/diagnosis , COVID-19/psychology , Child , Fatigue/rehabilitation , Fatigue/virology , Female , Headache/rehabilitation , Headache/virology , Humans , Male , Neuropsychological Tests , Quality of Life , SARS-CoV-2 , Post-Acute COVID-19 Syndrome
3.
Cancer Med ; 10(16): 5456-5465, 2021 08.
Article in English | MEDLINE | ID: mdl-34213086

ABSTRACT

BACKGROUND: Yoga is a meditative movement therapy focused on mind-body awareness. The impact of yoga on health-related quality of life (HRQOL) outcomes in patients with chemotherapy-induced peripheral neuropathy (CIPN) is unclear. METHODS: We conducted a pilot randomized wait-list controlled trial of 8 weeks of yoga (n = 21) versus wait-list control (n = 20) for CIPN in 41 breast and gynecological cancer survivors with persistent moderate to severe CIPN. HRQOL endpoints were Hospital Anxiety and Depression Scale (HADS), Brief Fatigue Inventory (BFI), and Insomnia Severity Index (ISI). The Treatment Expectancy Scale (TES) was administered at baseline. We estimated mean changes and 95% confidence intervals (CIs) from baseline to weeks 8 and 12 and compared arms using constrained linear mixed models. RESULTS: At week 8, HADS anxiety scores decreased -1.61 (-2.75, -0.46) in the yoga arm and -0.32 (-1.38, 0.75) points in the wait-list control arm (p = 0.099). At week 12, HADS anxiety scores decreased -1.42 (-2.57, -0.28) in yoga compared to an increase of 0.46 (-0.60, 1.53) in wait-list control (p = 0.017). There were no significant differences in HADS depression, BFI, or ISI scores between yoga and wait-list control. Baseline TES was significantly higher in yoga than in wait-list control (14.9 vs. 12.7, p = 0.019). TES was not associated with HADS anxiety reduction and HADS anxiety reduction was not associated with CIPN pain reduction. CONCLUSIONS: Yoga may reduce anxiety in patients with CIPN. Future studies are needed to confirm these findings. CLINICAL TRIAL REGISTRATION NUMBER: ClinicalTrials.gov Identifier: NCT03292328.


Subject(s)
Antineoplastic Agents/adverse effects , Neoplasms/drug therapy , Peripheral Nervous System Diseases/rehabilitation , Quality of Life , Yoga/psychology , Adult , Aged , Anxiety/diagnosis , Anxiety/psychology , Anxiety/rehabilitation , Cancer Survivors/psychology , Fatigue/chemically induced , Fatigue/diagnosis , Fatigue/rehabilitation , Female , Humans , Male , Middle Aged , Neoplasms/mortality , Neoplasms/psychology , Peripheral Nervous System Diseases/chemically induced , Peripheral Nervous System Diseases/psychology , Self Report/statistics & numerical data , Treatment Outcome
4.
Acta Med Port ; 34(3): 209-216, 2021 Mar 01.
Article in English | MEDLINE | ID: mdl-33971116

ABSTRACT

INTRODUCTION: The co-association of benzodiazepines and opioids is associated with an increased risk of overdose, death, and poorer psychosocial prognosis. The aim of this study is to characterize the prevalence, pattern of use, and primary clinical outcomes in benzodiazepines users in a public opioid maintenance treatment unit. MATERIAL AND METHODS: We conducted a cross-sectional study involving 236 patients treated with opioid substitutes (methadone and buprenorphine). We conducted a descriptive, bivariable, and multivariable analysis to determine clinical differences between benzodiazepines users and non-users. RESULTS: The prevalence of consumption of benzodiazepines was 25.4% (60). The benzodiazepines were obtained with a medical prescription (49.8%) or on the black market (42.6%). The most prescribed benzodiazepine was diazepam (29.1%), and the main reasons were to relieve insomnia (27.7%) or anxiety (26.9%) and to enhance the psychoactive effects of other drugs (19.7%). Regarding the clinical outcomes, we highlight: a very high prevalence of hepatitis C (51.7%); severe ongoing consumption of psychoactive drugs (73.7%); and a high rate of depression and anxiety (> 60%), significantly higher in the benzodiazepines-user group. In the multivariable analysis of benzodiazepine use, we found alcohol consumption (OR 0.482; IC 95% 0.247, 0.238) had a negative association and having hepatitis C (OR 2.544, IC 95% 1.273, 5.084) or anxiety symptoms (OR 5.591; IC 95% 2.345, 13.326) had positive associations. DISCUSSION: Our results suggest the BZD users had a complex drug addiction problem and underline the importance of adequately addressing BZD use, contemplating psychological and psychiatric approach in this particular population. CONCLUSION: Past or current use of benzodiazepines is associated with poor clinical and psychiatric outcomes. A multidisciplinary approach with a focus on infectious diseases and mental health is critical in order to enhance the treatment effectiveness and overall prognosis.


Introdução: A co-associação entre benzodiazepinas e opióides associa-se a risco aumentado de overdose, morte e pior prognóstico psicossocial. Pretendemos determinar a prevalência, o padrão de consumo e as principais co-morbilidades do uso de benzodiazepinas, em utentes sob tratamento de manutenção opióide. Material e Métodos: Conduzimos um estudo transversal, envolvendo 236 doentes tratados com substitutos opióides (metadona e buprenorfina). Realizou-se uma análise descritiva, bivariável e multivariável das características clínicas entre os usuários de benzodiazepinas e os não-usuários de benzodiazepinas. Resultados: A prevalência do uso de benzodiazepinas foi de 25,4% (60). A obtenção de benzodiazepinas foi através de prescrição médica (49,8%) ou mercado negro (42,6%). A substância mais prescrita foi o diazepam (29,1%), e as principais razões para a toma foi insónia (27,7%), ansiedade (26,9%), e para potenciar os efeitos psicoativos de outras drogas (19,7%). No que respeita aos resultados clínicos sublinhamos: prevalência elevada de hepatite C (51,7%); elevado consumo continuado de substâncias psicoativas (73,7%); elevada taxa de depressão e ansiedade (> 60%), significativamente mais elevada nos utilizadores de benzodiazepinas. Na análise multivariável para o uso de benzodiazepinas, verificámos que o consumo de álcool (OR 0,482; IC 95% 0,247, 0,238) tem associação negativa; a hepatite C (OR 2,544; IC 95% 1,273, 5,084) e a ansiedade (OR 5,591; IC 95% 2,345, 13,326) tiveram associações positivas. Discussão: Os resultados obtidos sugerem que os utilizadores de BZD têm um problema complexo de dependência de drogas e sublinham a importância de abordar adequadamente o uso de BZD, contemplando uma abordagem psicológica e psiquiátrica nesta população em particular. Conclusão: O uso de benzodiazepinas, no passado ou atualmente, associa-se a piores indicadores físicos e psiquiátricos. A abordagem multidisciplinar com foco nas doenças infeciosas e na saúde mental é uma necessidade crítica para a efetividade do tratamento e prognóstico global.


Subject(s)
Benzodiazepines/therapeutic use , Buprenorphine/therapeutic use , Diazepam/therapeutic use , Methadone/therapeutic use , Narcotics/therapeutic use , Opiate Substitution Treatment , Opioid-Related Disorders/psychology , Opioid-Related Disorders/rehabilitation , Adult , Analgesics, Opioid/therapeutic use , Anxiety/epidemiology , Anxiety/rehabilitation , Buprenorphine/adverse effects , Cross-Sectional Studies , Diazepam/adverse effects , Female , Humans , Male , Mental Disorders/epidemiology , Mental Disorders/rehabilitation , Methadone/adverse effects , Middle Aged , Opioid-Related Disorders/epidemiology , Portugal/epidemiology , Prevalence , Sleep Initiation and Maintenance Disorders/epidemiology , Sleep Initiation and Maintenance Disorders/rehabilitation , Surveys and Questionnaires , Treatment Outcome
5.
Medicine (Baltimore) ; 100(12): e25077, 2021 Mar 26.
Article in English | MEDLINE | ID: mdl-33761665

ABSTRACT

BACKGROUND: Music-supported therapy has been widely used clinically to relieve post-stroke rehabilitation. However, the efficacy of Music-supported therapy in the treatment of Mood in post-stroke rehabilitation Patients is uncertain. The purpose of this study is to determine the effectiveness and safety of Music-supported therapy in the treatment of Mood in post-stroke rehabilitation Patients. METHODS: Search PubMed, Cochrane Library, Embase, China National Knowledge Infrastructure Database, Wanfang Database, China Science and Technology Journal Database, China Biomedical Literature Database, and search related randomized controlled trials. Two reviewers will independently select studies, collect data, and evaluate methodological quality through the Cochrane Deviation Risk Tool. Revman V.5.3 will be used for meta-analysis. RESULTS: This study will evaluate the current status of Music-supported therapy treatment for mood in post-stroke rehabilitation Patients, aiming to illustrate the effectiveness and safety of Music-supported therapy treatment. CONCLUSION: This study will provide a basis for judging whether Music-supported therapy is effective in treating mood in post-stroke rehabilitation Patients. INPLASY REGISTRATION NUMBER: INPLASY202120011.


Subject(s)
Anxiety/rehabilitation , Depression/rehabilitation , Music Therapy/methods , Stroke Rehabilitation/methods , Stroke/psychology , Affect , Anxiety/etiology , Depression/etiology , Humans , Meta-Analysis as Topic , Randomized Controlled Trials as Topic , Research Design , Systematic Reviews as Topic , Treatment Outcome
6.
Arch Phys Med Rehabil ; 102(6): 1049-1058, 2021 06.
Article in English | MEDLINE | ID: mdl-33556352

ABSTRACT

OBJECTIVE: To determine and compare the effect of yoga, physical therapy (PT), and education on depressive and anxious symptoms in patients with chronic low back pain (CLBP). DESIGN: Secondary analysis of a randomized controlled trial. SETTING: Academic safety net hospital and 7 community health centers. PARTICIPANTS: A total of 320 adults with CLBP. INTERVENTION: Yoga classes, PT sessions, or an educational book. OUTCOME MEASURE: Depression and anxiety were measured using the Patient Health Questionnaire and Generalized Anxiety Disorder 7-item Scale, respectively, at baseline, 12, and 52 weeks. We identified baseline and midtreatment (6-wk) factors associated with clinically meaningful improvements in depressive (≥3 points) or anxious (≥2 points) symptoms at 12 weeks. RESULTS: Participants (female=64%; mean age, 46.0±10.7 years) were predominantly non-White (82%), low-income (<$30,000/year, 59%), and had not received a college degree (71%). Most participants had mild or worse depressive (60%) and anxious (50%) symptoms. At 12 weeks, yoga and PT participants experienced modest within-group improvements in depressive symptoms (mean difference [MD]=-1.23 [95% CI, -2.18 to -0.28]; MD=-1.01 [95% CI, -2.05 to -0.03], respectively). Compared with the education group, 12-week differences were not statistically significant, although trends favored yoga (MD=-0.71 [95% CI, -2.22 to 0.81]) and PT (MD= -0.32 [95% CI, -1.82 to 1.18]). At 12 weeks, improvements in anxious symptoms were only found in participants who had mild or moderate anxiety at baseline. Independent of treatment arm, participants who had 30% or greater improvement in pain or function midtreatment were more likely to have a clinically meaningful improvement in depressive symptoms (odds ratio [OR], 1.82 [95% CI, 1.03-3.22]; OR, 1.79 [95% CI, 1.06-3.04], respectively). CONCLUSIONS: In our secondary analysis we found that depression and anxiety, common in this sample of underserved adults with CLBP, may improve modestly with PT and yoga. However, effects were not superior to education. Improvements in pain and function are associated with a decrease in depressive symptoms. More research is needed to optimize the integration of physical and psychological well-being in PT and yoga.


Subject(s)
Anxiety/rehabilitation , Chronic Pain/psychology , Depression/rehabilitation , Low Back Pain/psychology , Patient Education as Topic/methods , Physical Therapy Modalities/psychology , Yoga/psychology , Adult , Anxiety/ethnology , Anxiety/etiology , Chronic Pain/ethnology , Chronic Pain/rehabilitation , Depression/ethnology , Depression/etiology , Female , Humans , Low Back Pain/ethnology , Low Back Pain/rehabilitation , Male , Middle Aged , Patient Health Questionnaire , Poverty/psychology , Racial Groups/psychology , Treatment Outcome
7.
Cancer Rep (Hoboken) ; 4(3): e1336, 2021 06.
Article in English | MEDLINE | ID: mdl-33586920

ABSTRACT

BACKGROUND: Prevalent symptoms that affect children and adolescents throughout the process of cancer diagnosis and treatment include nausea and vomiting, fatigue, pain, mucositis, and anxiety. AIM: To examine the effect of a home-based multimodal symptom-management program for alleviation of nausea and vomiting, fatigue, pain, mucositis, and anxiety in children and adolescents undergoing chemotherapy for hematological malignancies or solid tumors. METHODS: In an exploratory pilot randomized study with qualitative interview, patients between 10 and 18 years of age were randomly assigned to either the symptom-management program plus usual care (intervention group) or usual care (control group). The program consisted of multiple nonpharmacological interventional components. The targeted symptoms were measured at baseline (after diagnosis), at the first 2 weeks of each cycle of chemotherapy, and at 6 months after baseline, using the Memorial Symptom Assessment Scale 10-18 and the State Anxiety Scale for Children. RESULTS: Fifty children (31 boys; mean age, 13.7 years) were randomized either to the intervention group or the control group (25 each) and underwent baseline assessment. A comparison between the groups showed that the intervention group had a significant less fatigue over time (P < .05). However, no differences were found with respect to nausea and vomiting, pain, mucositis, and anxiety between groups. Both children and parents reported a positive experience with the symptom-management program. CONCLUSION: The home-based symptom-management program may have helped to reduce fatigue in children and adolescents undergoing chemotherapy. In addition, qualitative data support the importance of improving children and parents' knowledge, coping skills, and psychological preparation for symptoms associated with chemotherapy.


Subject(s)
Antineoplastic Agents/adverse effects , Caregivers/education , Home Care Services, Hospital-Based , Neoplasms/drug therapy , Patient Education as Topic/methods , Adaptation, Psychological , Adolescent , Anxiety/chemically induced , Anxiety/diagnosis , Anxiety/psychology , Anxiety/rehabilitation , Child , Fatigue/chemically induced , Fatigue/diagnosis , Fatigue/psychology , Fatigue/rehabilitation , Female , Humans , Male , Mucositis/chemically induced , Mucositis/diagnosis , Mucositis/psychology , Mucositis/rehabilitation , Nausea/chemically induced , Nausea/diagnosis , Nausea/psychology , Nausea/rehabilitation , Neoplasms/psychology , Pain/chemically induced , Pain/diagnosis , Pain/psychology , Pain/rehabilitation , Pilot Projects , Prospective Studies , Treatment Outcome , Vomiting/chemically induced , Vomiting/diagnosis , Vomiting/psychology , Vomiting/rehabilitation
8.
Neurorehabil Neural Repair ; 35(3): 290-299, 2021 03.
Article in English | MEDLINE | ID: mdl-33559531

ABSTRACT

BACKGROUND: Freezing of gait (FOG) is arguably the most disabling motor symptom experienced with Parkinson's disease (PD), but treatments are extremely limited due to our poor understanding of the underlying mechanisms. Three cortical domains are postulated in recent research (ie, the cognitive, limbic, and sensorimotor domains), thus, treatments targeting these mechanisms of FOG may potentially be effective. Cognitive training, cognitive behavioral therapy (CBT, a well-known anxiety intervention), and proprioceptive training may address the cognitive, limbic, and sensorimotor domains, respectively. OBJECTIVE: To investigate whether these 3 treatments could improve functional outcomes of FOG. METHODS: In a single-blind, randomized crossover design, 15 individuals with PD and FOG were randomized into different, counterbalanced orders of receiving the interventions. Each consisted of eight 1-hour sessions, twice weekly for 4 weeks. FOG severity was assessed as the primary outcome using a novel gait paradigm that was aimed at evoking FOG when the cognitive, limbic, or sensorimotor domains were independently challenged. RESULTS: FOG severity significantly improved after the cognitive intervention, with strong trends toward improvement specifically in the baseline and cognitive-challenge assessment conditions. CBT, as the anxiety intervention, resulted in significantly worse FOG severity. In contrast, proprioceptive training significantly improved FOG severity, with consistent trends across all conditions. CONCLUSIONS: The cognitive and proprioceptive treatments appeared to improve different aspects of FOG. Thus, either of these interventions could potentially be a viable treatment for FOG. However, although the results were statistically significant, they could be sensitive to the relatively small number of participants in the study. Considering the significant results together with nonsignificant trends in both FOG and gait measures, and given equal time for each intervention, proprioceptive training produced the most consistent indications of benefits in this study. (clinicaltrials.gov NCT03065127).


Subject(s)
Anxiety/rehabilitation , Cognitive Behavioral Therapy , Cognitive Dysfunction/rehabilitation , Cognitive Remediation , Gait Disorders, Neurologic/rehabilitation , Neurological Rehabilitation , Parkinson Disease/rehabilitation , Proprioception , Sensation Disorders/rehabilitation , Aged , Aged, 80 and over , Anxiety/etiology , Cognitive Dysfunction/etiology , Cross-Over Studies , Female , Gait Disorders, Neurologic/etiology , Humans , Limbic System/physiopathology , Male , Middle Aged , Neuropsychological Tests , Outcome Assessment, Health Care , Parkinson Disease/complications , Proprioception/physiology , Sensation Disorders/etiology , Severity of Illness Index , Single-Blind Method
9.
Scand J Psychol ; 62(1): 41-50, 2021 Feb.
Article in English | MEDLINE | ID: mdl-32745305

ABSTRACT

Acceptance and Commitment Therapy (ACT) is potentially effective for treating chronic fatigue. Given the paucity of studies on this topic, we aimed to assess long-term trajectories of primary (fatigue, quality of life and functional abilities) and secondary outcomes (anxious and depressive symptoms) of an ACT-based rehabilitation program for patients with chronic fatigue. Further, we examined if changes in potential process variables (psychological inflexibility, metacognitive beliefs, and cognitive and behavioral responses to symptoms) during ACT predicted change in all outcomes across follow-up. One-hundred ninety-five workers on sick leave (mean age: 43.61 ± 9.33 years; 80.5% females) with a diagnosis of chronic fatigue were enrolled in a manualized, 3.5-week intensive return-to-work rehabilitation program based on ACT. All completed a battery of questionnaires at pre-, post-treatment, 6 and 12 months follow-up. We found significant longitudinal changes in most primary and secondary outcomes from pre- up to 12 months follow-up. All process variables significantly decreased from pre- up to 12 months follow-up, and pre-to-post changes in fear avoidance beliefs were most often associated with a greater change in outcomes across follow-up. Depressive symptomatology showed a similar trajectory of change to fatigue, meaning that scores were correlated at each time point and tended to converge over time. This suggests that both symptoms influence each other substantially over a year following the treatment. Concluding, results lend support to the effectiveness of an ACT-based rehabilitation program for patients with chronic fatigue and provide preliminary evidence for the role of process variables and depressive symptomatology on subsequent change in outcomes.


Subject(s)
Acceptance and Commitment Therapy , Fatigue Syndrome, Chronic/rehabilitation , Quality of Life/psychology , Return to Work/psychology , Adult , Anxiety/psychology , Anxiety/rehabilitation , Depression/psychology , Depression/rehabilitation , Fatigue Syndrome, Chronic/psychology , Female , Humans , Longitudinal Studies , Male , Metacognition , Middle Aged , Surveys and Questionnaires , Treatment Outcome
10.
Parkinsonism Relat Disord ; 82: 50-55, 2021 01.
Article in English | MEDLINE | ID: mdl-33248393

ABSTRACT

INTRODUCTION: Functional Movement Disorders (FMDs) are challenging to treat. We assessed the effect of multidisciplinary inpatient rehabilitation, involving motor retraining, psychotherapy and psychotropic medication on FMD patient function and maintenance of improvement after one year. METHODS: FMD patients in a movement disorders clinic were referred for inpatient rehabilitation. Baseline, discharge and one year follow-up measures included: Clinical Global Impression (CGI-severity, CGI-change); Depression and Somatic Symptom Scale (DSSS); Generalized Anxiety Disorder-7 (GAD-7); Patient Health Questionnaire-9 (PHQ-9); Post-traumatic stress disorder check-list for DSM-5 (PCL-5). Outcomes were analyzed with non-parametric models. RESULTS: Seventeen patients completed rehabilitation. Thirteen completed one-year follow-up. Median CGI-severity was "markedly ill." At discharge, movement disorder improved in 93% (median CGI-change = 2, "much improved") as assessed by neurologist and patient. Psychiatrist ratings showed improvement among 86.7%; physiatrist and psychologist ratings were 66.7% and 53.3%, respectively. Symptoms improved on DSSS (Wilcoxon Z = -2.914, p ≤ 0.004); GAD-7 (Z = -3.045, p ≤ 0.002); PHQ-9 (Z = -3.415, p ≤ 0.01) but not PCL-5 (Z = -1.506, p = 0.132). At 1 year, 54% maintained at least minimal improvement by neurologist rating and 77% by patient rating (median CGI-change = 3, "minimally improved"). Improvement was not maintained for DSSS (Wilcoxon Z = -0.385. p = 0.701), GAD-7 (Z = -0.943, p = 0.357) or PHQ-9 (Z = -0.55, p = 0.582). CONCLUSIONS: Multidisciplinary inpatient rehabilitation improved FMD patient function, depression, anxiety and somatic symptoms. One-year follow-up demonstrated minimal sustained improvement and worsening psychopathology, reflecting chronic debility despite initial rehabilitative success.


Subject(s)
Anxiety/rehabilitation , Conversion Disorder/rehabilitation , Depression/rehabilitation , Gait Disorders, Neurologic/rehabilitation , Movement Disorders/rehabilitation , Neurological Rehabilitation , Outcome Assessment, Health Care , Tremor/rehabilitation , Adult , Aged , Female , Follow-Up Studies , Humans , Inpatients , Male , Middle Aged , Severity of Illness Index , Young Adult
11.
Work ; 66(4): 731-737, 2020.
Article in English | MEDLINE | ID: mdl-32925134

ABSTRACT

BACKGROUND: The COVID-19 pandemic has become a major cause of stress and anxiety worldwide. Due to the global lockdown, work, employment, businesses and the economic climate have been severely affected. It has generated stress among people from all sections of society, especially to workers who have been assigned to cater to healthcare service or those constrained to secure daily essential items. It is widely perceived that elderly or those affected by diabetes, hypertension and other cardiovascular diseases are prone to COVID-19. As per an ongoing survey, the initial data shows that the above-mentioned anxiety and stress cause insomnia, and has the considerable potential to weaken the immune system, the sole protection against the virus. OBJECTIVE: This study focuses on the need of Yoga practice at work places and at home during the global lockdown due to the COVID-19 pandemic. METHODS: Literature was searched using PubMed and Google Scholar for COVID-19-related stress and anxiety at work and society due to the worldwide lockdown. The predisposing comorbidities, viral mechanism of action and treatment regimen were also searched. Yoga-based intervention studies and online programs were also searched. RESULTS: As the lockdown cannot last forever and workplaces will have to be functional soon, there is an increased possibility of recurrent infection. Therefore, Yoga can provide the necessary tool for risk reduction, amelioration of stress and anxiety and strengthening of the immune function. The online platforms provide a good media for Yoga training at work places and homes. CONCLUSION: Due to social distancing norms, the availability of Yoga trainers has become restricted. Yoga practice is actively sought to achieve reduced anxiety and stress so that improved sleep may positively impact immunity. As a consequence, there is a spurt in social media, catering to daily online Yoga sessions which apparently prove useful in providing accessible means to achieve mental as well as physical well-being.


Subject(s)
Coronavirus Infections/psychology , Immune System/physiology , Pneumonia, Viral/psychology , Sleep Initiation and Maintenance Disorders/prevention & control , Telecommunications , Yoga , Anxiety/complications , Anxiety/psychology , Anxiety/rehabilitation , Betacoronavirus/immunology , Betacoronavirus/pathogenicity , COVID-19 , Coronavirus Infections/epidemiology , Coronavirus Infections/immunology , Coronavirus Infections/prevention & control , Humans , Infection Control/standards , Pandemics/prevention & control , Pneumonia, Viral/epidemiology , Pneumonia, Viral/immunology , Pneumonia, Viral/prevention & control , SARS-CoV-2 , Sleep Initiation and Maintenance Disorders/immunology , Sleep Initiation and Maintenance Disorders/physiopathology , Sleep Initiation and Maintenance Disorders/psychology , Stress, Psychological/complications , Stress, Psychological/psychology , Stress, Psychological/rehabilitation , Workplace/psychology
13.
Psychiatry Res ; 293: 113371, 2020 11.
Article in English | MEDLINE | ID: mdl-32827994

ABSTRACT

Schizophrenia is one of the chronic mental disorders characterized by disturbances in thought, emotion, language, perception, and behavior. There is no cure for this disease, and most of the current treatments are palliative. In this study, we aimed to analyze the application of electroencephalographic (EEG) biofeedback therapy, an adjunctive treatment used for many psychiatric disorders, in the rehabilitation of schizophrenic patients. Schizophrenic patients were selected as the experimental subjects, and the initial diagnosis criteria were set accordingly. A primary and a secondary efficacy index was then developed for the evaluation of EEG biofeedback therapy rather than traditional drug treatment. Lastly, the effects of the two methods were compared. The findings indicate that traditional drugs could be used in the treatment of mild schizophrenia, but showed poor results for severe and moderate schizophrenia. EEG biofeedback therapy was effective for the treatment of various degrees of schizophrenia and improved patients' sleep quality and anxiety. These findings have significant practical implications for the rehabilitation of schizophrenic patients and patients with chronic diseases in general.


Subject(s)
Biofeedback, Psychology/methods , Electroencephalography/methods , Electroencephalography/psychology , Schizophrenia/therapy , Schizophrenic Psychology , Adolescent , Adult , Aged , Anxiety/psychology , Anxiety/rehabilitation , Anxiety/therapy , Chronic Disease , Female , Humans , Male , Medicine, Chinese Traditional/methods , Medicine, Chinese Traditional/psychology , Middle Aged , Schizophrenia/rehabilitation , Sleep/physiology , Young Adult
14.
Future Oncol ; 16(29): 2283-2293, 2020 Oct.
Article in English | MEDLINE | ID: mdl-32677462

ABSTRACT

Aim: To investigate how COVID-19 fear and anxiety (COV-FA) affects chemotherapy adherence in patients with cancer. Materials & methods: The records of 3661 patients with chemotherapy (CT) appointments were retrospectively reviewed. Results: The CT postponement rates before and after COVID-19 were 11.6% and 14.2%, respectively (p = 0.017). The rate of COV-FA-related CT postponement after telemedicine was lower than that before (4.6% vs 17.4%; p = 0.012). The median time to come back to treatment of the COV-FA group was 47 days (range 19-72 days). Advanced age (≥60 years) was found to be the independent factor that was predictive of time to come back to treatment (p = 0.043). Conclusion: The CT postponement rate increased after COVID-19. COV-FA-related CT postponement decreased after telemedicine. Advanced age could be predictive of time to come back to treatment.


Subject(s)
Antineoplastic Agents/therapeutic use , Betacoronavirus/immunology , Coronavirus Infections/psychology , Medication Adherence/statistics & numerical data , Neoplasms/drug therapy , Pneumonia, Viral/psychology , Age Factors , Aged , Anxiety/epidemiology , Anxiety/etiology , Anxiety/psychology , Anxiety/rehabilitation , Betacoronavirus/pathogenicity , COVID-19 , Coronavirus Infections/epidemiology , Coronavirus Infections/immunology , Coronavirus Infections/transmission , Fear/psychology , Female , Humans , Infection Control/standards , Male , Medical Oncology/methods , Medical Oncology/organization & administration , Medical Oncology/standards , Medication Adherence/psychology , Middle Aged , Neoplasms/immunology , Neoplasms/psychology , No-Show Patients/psychology , No-Show Patients/statistics & numerical data , Pandemics , Pneumonia, Viral/epidemiology , Pneumonia, Viral/immunology , Pneumonia, Viral/transmission , Psychometrics/statistics & numerical data , Retrospective Studies , SARS-CoV-2 , Self Report/statistics & numerical data , Telemedicine/methods , Telemedicine/organization & administration , Telemedicine/standards
16.
Cuad. psicol. deporte ; 20(3): 1-14, jul. 2020. tab
Article in Spanish | IBECS | ID: ibc-193536

ABSTRACT

Diversas investigaciones han determinado que la implementación de programas de actividad física mejora la salud mental. Sin embargo, aún existen dudas sobre los beneficios de los programas Zumba® en la población que lo practica. El propósito de este estudio fue determinar los efectos de un programa de ejercicio físico basado en Zumba®, sobre los niveles de ansiedad-rasgo y ansiedad-estado en estudiantes universitarias chilenas. Investigación cuantitativa cuasi-experimental, con una muestra de 22 estudiantes mujeres de pregrado (grupo experimental = 10 y grupo control = 12). Las variables fueron: ansiedad-rasgo (A-R) y ansiedad-estado (A-E), además de variables físicas como antropometría, consumo máximo de oxígeno (VO2máx) y fuerza prensil. El análisis estadístico se realizó a través de un ANOVA mixto para todas las variables. En nivel de significancia fue de p < 0,05. Los resultados evidenciaron cambios no significativos en los distintos niveles de A-R ni A-E luego de la aplicación del programa de Zumba® (p > 0,05), tampoco hubo cambios en las otras variables de estudio (p > 0,05). Al término de la intervención, no se observaron efectos del programa de Zumba® sobre los distintos niveles de A-R y A-E, como tampoco sobre variables antropométricas, VO2máx ni fuerza prensil


Several investigations have specified that the implementation of physical activity programs improve mental health. However, there are still doubts about the benefits on the population taking part in Zumba® programs. The purpose of this study was to determine the effects of a Zumba® based working out program on the levels of anxiety-trait and anxiety-state in Chilean university students. It was a quantitative, cuasi-experimental study with a sample of 22 undergraduate female students (experimental group = 10 and control group = 12). The variables were anxiety-trait (A-T) and anxiety-state (A-S), in addition to physical variables, such as anthropometry, maximum oxygen consumption (VO2max) and grip strength. A statistical analysis was performed through a mixed ANOVA. The level of significance for all analyses was p < 0.05. The results showed no significant changes in the different levels of A-T or A-S (p > 0.05), there were also no changes in the other variables (p > 0.05). At the end of the intervention, no effects of the Zumba® program were observed on the different levels of A-T and A-S, nor on anthropometric variables, VO2max or grip strength


Várias investigações determinaram que a implementação de programas de atividade física melhora a saúde mental. No entanto, ainda existem dúvidas sobre os benefícios dos programas Zumba® na população que pratica. O objetivo deste estudo foi determinar os efeitos de um programa de exercícios físicos baseado no Zumba®, sobre níveis de Ansiedade-Traço e Ansiedade-Estado em estudantes universitários chilenos. Pesquisa quantitativa quase experimental, com uma amostra de 22 estudantes do sexo feminino (grupo experimental [GE] = 10 e grupo controle [GC] = 12). As variáveis foram: Ansiedade-Traço (A-T) e Ansiedade-Estado (A-E), ambas avaliadas pelo STAI Trait State Anxiety Questionnaire, além de variáveis físicas como antropometria, consumo máximo de oxigênio (VO2máx) e força pré-trilateral. A análise estatística foi realizada através de uma ANOVA mista para todas as variáveis e uma tabela de contingência por meio do Qui-Quadrado de Pearson para os diferentes níveis de A-T e A-E. O nível de significância para todas as análises foi de p <0,05. Os resultados não mostraram alterações significativas em todas as variáveis do estudo após a aplicação do programa Zumba® (p> 0,05); também não houve diferenças nos diferentes níveis de A-T ou A-E (p> 0,05). Ao final da intervenção, não foram observados efeitos do programa Zumba® sobre diferentes níveis de A-R e A-E, nem nas variáveis antropométricas, VO2máx ou força preênsil


Subject(s)
Humans , Female , Young Adult , Adult , Dancing/psychology , Students/psychology , Anxiety/psychology , Motor Activity , Anxiety/rehabilitation , Longitudinal Studies , Surveys and Questionnaires , Universities , Chile , Anthropometry , Oxygen Consumption , Case-Control Studies
17.
Psychosom Med ; 82(6): 600-613, 2020.
Article in English | MEDLINE | ID: mdl-32541543

ABSTRACT

OBJECTIVE: The study aims to meta-analytically review studies about the effects of mindfulness-based interventions (MBIs) on well-being of people with multiple sclerosis (MS). METHODS: Seven electronic databases were searched from June 2018 to September 2018. A systematic review and a meta-analysis were conducted. RESULTS: Twenty-one studies were included in qualitative synthesis, and 10 studies were included in meta-analysis. MBIs are effective with an overall moderate effect size (Hedges' g = 0.70) in improving well-being in people with MS, with lasting effects at the follow-up (g = 0.55). In particular, MBIs demonstrated to highly reduce stress (g = 1.07) and to improve depression and anxiety symptoms with a moderate to large effect at postintervention (g = 0.77 and g = 0.63, respectively). CONCLUSIONS: MBIs represent a valid and effective mind-body intervention to improve the well-being of patients with MS. Further studies should investigate which components of MBIs could be more beneficial for patients with progressive MS. PROSPERO REGISTRATION: CRD42018099704.


Subject(s)
Anxiety/rehabilitation , Depression/rehabilitation , Mindfulness , Multiple Sclerosis/rehabilitation , Personal Satisfaction , Anxiety/etiology , Depression/etiology , Humans , Multiple Sclerosis/complications , Multiple Sclerosis/psychology
18.
Behav Brain Res ; 390: 112617, 2020 07 15.
Article in English | MEDLINE | ID: mdl-32428636

ABSTRACT

BACKGROUND: Behavioural and Psychiatric Symptoms in dementia (BPSD) tend to be a crucial and big problem in dementia. Anxiety several times remains under-diagnosed because it is often considered to be a psychological response to cognitive decline. As only the 10 % of patients were correctly treated, the pharmacological treatment should be well- considered. The aim of this study was to evaluate three non-pharmacological interventions for the treatment of anxiety in dementia. METHODS: A cross-over randomised controlled trial with 60 participants (different types and stages of dementia) conducted in Greece. The sample was randomly assigned to 6 different groups of 10 participants each. The non-pharmacological interventions that have been evaluated are: a) Music Therapy b) Exercise and c) Aromatherapy & Massage. The measurements that were used are: MMSE, ACE-R, GDS, FRSSD and NPI questionnaire. The interventions lasted 5 days and there was two days off as a wash-out period. There was no drop-out rate. RESULTS: The study showed that the most effective intervention is Music therapy. The second most effective intervention is Exercise and the third one is Aromatherapy and Massage. In the parenthesis p results indicate that Music Therapy's p is less than 0.05 in comparison with Exercise and Aromatherapy and Massage and therefore the sequence of the interventions does not interfere with the results. (p = <0.05, p = 0.55, accordingly). Caregivers' burden also reduced with MT. In the parenthesis p results indicate Music Therapy's p is less than 0.05 in comparison with the two other interventions and therefore the sequence of the interventions does not interfere with the results, as well (p = <0.05, p = 0.19). CONCLUSIONS: Our results are in accordance with the current literature. Music Therapy is a promising alternative intervention for the treatment of anxiety in PwD. Music Therapy is an effective non-pharmacological treatment for the reduction of the caregivers' burden, because of the anxiety symptoms in PwD, such as lack of sleep, lack of personal time, unhealthy lifestyle, lack of solutions on what to do with their patients etc. The type of music, the duration of the intervention and the long-term benefits remain unclear. There is a big need of further research with stronger possible evaluation methods.


Subject(s)
Anxiety/rehabilitation , Caregiver Burden/therapy , Dementia/rehabilitation , Exercise Therapy , Music Therapy , Aged , Aged, 80 and over , Anxiety/etiology , Anxiety Disorders , Aromatherapy , Cross-Over Studies , Dementia/complications , Female , Humans , Male , Massage , Outcome Assessment, Health Care
20.
Psychol Health Med ; 25(10): 1179-1191, 2020 12.
Article in English | MEDLINE | ID: mdl-32129673

ABSTRACT

This study aimed to assess the effects of cognitive behavioral therapy on the psychological and physiological health of rheumatoid arthritis patients. An extensive literature search was conducted, using the PubMed, Web of Science, Cochrane Library, Embase, CNKI Scholar, WanFang, and VIP databases, from inception to December2018. The quality of the studies was evaluated by 2 independent authors, according to the basic criteria provided by the Cochrane Handbook for evaluating randomized trials. Meta-analysis was performed with Review Manager 5.3. Six randomized controlled trials met the inclusion criteria of the current study. Using standard mean differences (SMD) and 95% confidence intervals (CI), our results showed that cognitive behavioral therapy could significantly reduce levels of anxiety (SMD = -0.30, 95% CI [-0.52, -0.09], P= 0.005) and depression (SMD = -0.48, 95% CI [-0.70, -0.27], P< 0.00001), and relieve fatigue symptoms (SMD = -0.35, 95% CI [-0.60, -0.10], P= 0.006) in rheumatoid arthritis patients.This is the first known assessment of the efficacy of cognitive behavioral therapy on rheumatoid arthritis patients using meta-analysis. Large-scale randomized controlled trials need to be implemented to further explore this issue.


Subject(s)
Anxiety/rehabilitation , Arthritis, Rheumatoid/psychology , Arthritis, Rheumatoid/rehabilitation , Cognitive Behavioral Therapy , Fatigue/rehabilitation , Humans
SELECTION OF CITATIONS
SEARCH DETAIL
...